Source: MEDICAL DEVICES BUSINESS REVIEW

LGC: KASP chemistry enables rare coding variant to be tested for association with Alzheimer's disease

LGC's proprietary KASP genotyping assay has been successfully compared to an alternative technology for designing custom genotyping assays.

Read full article »
Est. Annual Revenue
$25-100M
Est. Employees
100-250
Mark Dearden's photo - Managing Director of LGC Genomics

Managing Director

Mark Dearden

CEO Approval Rating

- -/100

Read more